Adapted risk stratification and intensive chemotherapy abrogate the poor prognosis of pediatric B acute lymphoblastic leukemia with intrachromosomal amplification of chromosome 21 (iAMP21): a National cohort analysis

Click to increase image sizeClick to decrease image size AcknowledgementsThe authors to acknowledge all the staff involved in the care of these patients and of course the patients and families themselves.Disclosure statementNo potential conflict of interest was reported by the author(s).Data availability statementThe data that support the findings of this study are available on request from the corresponding author, AT. The data are not publicly available due to their containing information that could compromise the privacy of research participants.Additional informationFundingThe author(s) reported there is no funding associated with the work featured in this article.